IntelliPharmaCeutics International (TSXV:IPCI) Operating Cash Flow per Share : C$0.01 (TTM As of Aug. 2023)

View and export this data going back to 1999. Start your Free Trial

What is IntelliPharmaCeutics International Operating Cash Flow per Share?

IntelliPharmaCeutics International's operating cash flow per share for the three months ended in Aug. 2023 was C$0.01. IntelliPharmaCeutics International's operating cash flow per share for the trailing twelve months (TTM) ended in Aug. 2023 was C$0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 48.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for IntelliPharmaCeutics International's Operating Cash Flow per Share or its related term are showing as below:

TSXV:IPCI' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -44 Med: 10.4 Max: 68.8
Current: 48.5

During the past 13 years, IntelliPharmaCeutics International's highest 3-Year average Operating Cash Flow per Share Growth Rate was 68.80% per year. The lowest was -44.00% per year. And the median was 10.40% per year.

TSXV:IPCI's 3-Year OCF Growth Rate is ranked better than
90.86% of 1237 companies
in the Biotechnology industry
Industry Median: 3.6 vs TSXV:IPCI: 48.50

IntelliPharmaCeutics International Operating Cash Flow per Share Historical Data

The historical data trend for IntelliPharmaCeutics International's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Operating Cash Flow per Share Chart

IntelliPharmaCeutics International Annual Data

Trend

Nov13

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Operating Cash Flow per Share

Get a 7-Day Free Trial

-3.47

-0.41

0.01

-0.11

-0.06

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.01	-0.01	-	-	0.01

Competitive Comparison of IntelliPharmaCeutics International's Operating Cash Flow per Share

For the Biotechnology subindustry, IntelliPharmaCeutics International's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IntelliPharmaCeutics International's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Price-to-Operating-Cash-Flow falls into.

IntelliPharmaCeutics International Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

IntelliPharmaCeutics International's Operating Cash Flow per Share for the fiscal year that ended in Nov. 2022 is calculated as

Operating Cash Flow per Share (A: Nov. 2022 )	=	Cash Flow from Operations (A: Nov. 2022 )	/	Shares Outstanding (Diluted Average) (A: Nov. 2022 )
	=	-1.868	/	33.093
	=	-0.06

IntelliPharmaCeutics International's Operating Cash Flow per Share for the quarter that ended in Nov. 2022 is calculated as

Operating Cash Flow per Share (Q: Aug. 2023 )	=	Cash Flow from Operations (Q: Aug. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Aug. 2023 )
	=	0.325	/	33.093
	=	0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.01

IntelliPharmaCeutics International Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (TSXV:IPCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (TSXV:IPCI) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

IPCIF:USA I4AA:Germany

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (TSXV:IPCI) Headlines

No Headlines